Article Publish Status: FREE
Abstract Title:

Cannabidiol Acts at 5-HTReceptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy.

Abstract Source:

Front Behav Neurosci. 2020 ;14:611278. Epub 2020 Dec 15. PMID: 33384591

Abstract Author(s):

Christopher Martínez-Aguirre, Francia Carmona-Cruz, Ana Luisa Velasco, Francisco Velasco, Gustavo Aguado-Carrillo, Manola Cuéllar-Herrera, Luisa Rocha

Article Affiliation:

Christopher Martínez-Aguirre


Experimental evidence indicates that cannabidiol (CBD) induces anxiolytic and antiepileptic effects through the activation of 5-HTreceptors. These receptors are coupled to Gproteins and induce inhibitory effects. At present, the interaction of CBD with 5-HTreceptors in the human brain is unknown. The aim of this study focused on evaluating the interaction between CBD and 5-HTreceptors in cell membranes obtained from the hippocampus and temporal neocortex of autopsies and patients with drug-resistant mesial temporal lobe epilepsy (DR-MTLE). Cell membranes were isolated from the hippocampus and temporal neocortex of a group of patients with DR-MTLE who were submitted to epilepsy surgery (= 11) and from a group of autopsies (= 11). The [H]-8-OH-DPAT binding assay was used to determine the pharmacological interaction of CBD with 5-HTreceptors. The [S]-GTPγS assay was used to investigate the CBD-induced activation of Gproteins through its action on 5-HTreceptors.The CBD affinity (p) for 5-HTreceptors was similar for autopsies and patients with DR-MTLE (hippocampus: 4.29 and 4.47, respectively; temporal neocortex: 4.67 and 4.74, respectively). Concerning the [S]-GTPγS assay, no statistically significant changes were observed for both hippocampal and neocortical tissue (>0.05) at low CBD concentrations (1 pM to 10μM). In contrast, at high concentrations (100 μM), CBD reduced the constitutive activity of Gproteins of autopsies and DR-MTLE patients (hippocampus: 39.2% and 39.6%, respectively; temporal neocortex: 35.2% and 24.4%, respectively). These changes were partially reversed in the presence of WAY-100635, an antagonist of 5-HTreceptors, in the autopsy group (hippocampus, 59.8%,<0.0001; temporal neocortex, 71.5%,<0.0001) and the group of patients with DR-MTLE (hippocampus, 53.7%,<0.0001; temporal neocortex, 68.5%,<0.001). Our results show that CBD interacts with human 5-HTreceptors of the hippocampus and temporal neocortex. At low concentrations, the effect of CBD upon Gprotein activation is limited. However, at high concentrations, CBD acts as an inverse agonist of 5-HTreceptors. This effect could modify neuronal excitation and epileptic seizures in patients with DR-MTLE.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.